In another study, the authors used a combination of DD7-IL7 and B7H3 CAR-T in vitro and showed increased proliferation and persistence of tumor-infiltrating B7H3 CAR-T for glioblastoma treatment (63). Here, CD276 is linked to glioblastoma.